• 1
    Aronow WS, Feig JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2011; 57:20372114.
  • 2
    Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358: 18871898.
  • 3
    Lavie CJ, Messerli FH, Milani RV. Beta-blockers as first-line antihypertensive therapy: the crumbling continues. J Am Coll Cardiol. 2009;54:11621164.
  • 4
    Bangalore S, Kumar S, Lobach I, et al. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and Bayesian random-effects meta-analyses of randomized trials. Circulation. 2011;123:27992810.
  • 5
    De la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory pressure monitoring. Hypertension. 2011;57:898902.
  • 6
    Epstein M, Calhoun DA. The role of aldosterone in resistant hypertension: implications for pathogenesis and therapy. Curr Hypertens Rep. 2007;9:98105.